In a comprehensive review of biomarkers for response of melanoma to checkpoint inhibition, Jessurun et al. found a significant correlation between tumor PD-1 and PD-L1 expression and response to checkpoint inhibition in five out of eight analyses. This evidence concerns the gene PDCD1 and neoplasm.